CN112430249A - Metal complex and preparation method thereof - Google Patents

Metal complex and preparation method thereof Download PDF

Info

Publication number
CN112430249A
CN112430249A CN202011302489.XA CN202011302489A CN112430249A CN 112430249 A CN112430249 A CN 112430249A CN 202011302489 A CN202011302489 A CN 202011302489A CN 112430249 A CN112430249 A CN 112430249A
Authority
CN
China
Prior art keywords
alkyl
group
radical
aryl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011302489.XA
Other languages
Chinese (zh)
Inventor
黄湧
陈杰安
李恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Bay Laboratory Pingshan Biomedical R & D And Transformation Center
Original Assignee
Shenzhen Bay Laboratory Pingshan Biomedical R & D And Transformation Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Bay Laboratory Pingshan Biomedical R & D And Transformation Center filed Critical Shenzhen Bay Laboratory Pingshan Biomedical R & D And Transformation Center
Priority to CN202011302489.XA priority Critical patent/CN112430249A/en
Publication of CN112430249A publication Critical patent/CN112430249A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/006Palladium compounds
    • C07F15/0066Palladium compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The application belongs to the technical field of organic synthetic chemistry, and particularly relates to a metal complex and a preparation method thereof. The molecular structure general formula of the metal complex is shown as an instruction formula I; the metal complex is a complex of a chiral phosphorus-sulfur compound and a metal, has a typical high-functional group structure, such as a chiral quaternary carbon atom containing an electron-withdrawing group and an amino group, has a classical organic metal complex structure, widens the coordination of the phosphorus-sulfur compound, can expand organic asymmetric catalytic reaction, and has good application in the synthesis of a drug intermediate and the preparation of a functional material.

Description

Metal complex and preparation method thereof
Technical Field
The application belongs to the technical field of organic synthetic chemistry, and particularly relates to a metal complex and a preparation method thereof.
Background
Complexes with bidentate or tridentate ligand scaffolds are of interest for their wide application in organometallic complexes. To the first, after asymmetric synthesis applications have been discovered, chiral derivatives have received great attention among these compounds, and they have a wide range of application prospects in the fields of organic synthetic chemistry, biochemistry, asymmetric catalysis, pesticides, and medical research.
Metal complexes, in particular chiral cyclopalladated complexes, have been used primarily in cycloaddition and hydrogenation functionalization reactions during the last decade. These synthetically challenging diphosphorus and phosphorus-nitrogen bidentate ligands can form five-or six-membered ring chelates with the metal center, thereby avoiding catalyst poisoning. Optically pure Csp2-E type metal complexes can also be successfully used to catalyze asymmetric Michael addition reactions, Hayashi-Miyaura arylboronic acid additions, 3-single bond transfer heteroclaisen repps, ring opening reactions, and the like.
Currently, activation of Csp by carbon-hydrogen bonds is useful3-H, building pentapentacyclic palladium metal complexes. However, these methods suffer from a number of disadvantages, such as 1) a multi-heteroatom rich backbone has not been achieved; 2) biocompatible frameworks rich in trifluoromethyl and the like are not realized; 3) the framework of coordination of both teeth of the amide-containing and the phosphorus-sulfur compound has not been realized.
Disclosure of Invention
The application aims to provide a metal complex and a preparation method thereof, and aims to solve the technical problem of how to realize the complexation of a chiral phosphorus-sulfur compound and a metal.
In order to achieve the purpose of the application, the technical scheme adopted by the application is as follows:
in a first aspect, the present application provides a metal complex, wherein the molecular structure of the metal complex is represented by formula i:
Figure BDA0002787250550000021
wherein the content of the first and second substances,
R1、R2、R3and R5Are identical or different C1-C20Alkyl radical, C1-C20Heteroalkyl group, C3-C20Cycloalkyl radical, C3-C20Heterocycloalkyl radical, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C3-C20Cycloalkenyl radical, C3-C20Heterocycloalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, C3-C20Cycloalkynyl group, C3-C20Heterocycloalkynyl, C1-C20Alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, heteroaryloxy, aryl (C)1-C20) Alkyl, heteroaryl (C)1-C20) Alkyl radical, C2-C20Alkenyl (C)1-C20) Alkyl radical, C2-C20Alkynyl (C)1-C20) Alkyl, cyano (C)1-C20) Alkyl and C1-C20Alkyloxycarbonyl (C)1-C20) Any one of alkyl groups;
R4is hydrogen atom, cyano, C1-C20Ester group, C1-C20Alkyl radical, C1-C20Heteroalkyl group, C1-C20Haloalkyl, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, aryl (C)1-C20) Alkyl radical, C2-C10Alkenyl (C)1-C20) Alkyl and C2-C10Alkynyl (C)1-C20) Any one of alkyl groups;
R6is a halogen atom, C1-C5Ester group, C1-C5Borate ester group, C1-C5Phosphate group and C1-C5Any one of sulfonate groups;
m is any one of palladium, iridium, rhodium, manganese, nickel, platinum, gold, lithium and copper.
The metal complex provided by the application is a complex of a chiral phosphorus-sulfur compound and a metal, has a typical high-functional group structure, such as a chiral quaternary carbon atom containing an electron-withdrawing group and an amino group, has a classical organic metal complex structure, widens the coordination of the phosphorus-sulfur compound, can expand organic asymmetric catalytic reaction, and has good application in the synthesis of a drug intermediate and the preparation of a functional material.
In a second aspect, the present application provides a method for preparing a metal complex, comprising the steps of:
providing a chiral beta-nitro phosphorus sulfur compound A and a carboxylic acid compound B;
adding the chiral beta-nitro-phosphorus-sulfur compound A into a reaction system containing reducing metal, hydrochloric acid or trimethylchlorosilane for reaction to obtain a chiral beta-amino-phosphorus-sulfur compound C;
adding the chiral beta-aminophosphonium sulfur compound C into a reaction system containing the carboxylic acid compound B, a condensing agent and an alkali reagent to react to obtain a chiral beta-amidophosphorothioic compound ligand D;
adding the chiral beta-amidophosphorothioic compound ligand D into a metal compound MR6Reacting in the reaction system to obtain a metal complex shown as a formula I;
the structural general formula of the compound is as follows:
Figure BDA0002787250550000031
wherein the content of the first and second substances,
R1、R2、R3and R5Are identical or different C1-C20Alkyl radical, C1-C20Heteroalkyl group, C3-C20Cycloalkyl radical, C3-C20Heterocycloalkyl radical, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C3-C20Cycloalkenyl radical, C3-C20Heterocycloalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, C3-C20Cycloalkynyl group, C3-C20Heterocycloalkynyl, C1-C20Alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, heteroaryloxy, aryl (C)1-C20) Alkyl, heteroaryl (C)1-C20) Alkyl radical, C2-C20Alkenyl (C)1-C20) Alkyl radical, C2-C20Alkynyl (C)1-C20) Alkyl, cyano (C)1-C20) Alkyl and C1-C20Alkyloxycarbonyl (C)1-C20) Any one of alkyl groups;
R4is hydrogen atom, cyano, C1-C20Ester group, C1-C20Alkyl radical, C1-C20Heteroalkyl group, C1-C20Haloalkyl, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, aryl (C)1-C20) Alkyl radical, C2-C10Alkenyl (C)1-C20) Alkyl and C2-C10Alkynyl (C)1-C20) Any one of alkyl groups;
R6is a halogen atom, C1-C5Ester group, C1-C5Borate ester group, C1-C5Phosphate group and C1-C5Any one of sulfonate groups;
m is any one of palladium, iridium, rhodium, manganese, nickel, platinum, gold, lithium and copper.
The preparation method of the metal complex is a complex preparation method of a chiral phosphorus-sulfur compound and a metal complex, and comprises the steps of reducing a chiral beta-nitro phosphorus-sulfur compound A to obtain a chiral beta-amino phosphorus-sulfur compound C, condensing the chiral beta-amino phosphorus-sulfur compound C with a carboxylic acid compound B to obtain a chiral beta-amido phosphorus-sulfur compound ligand D, and finally complexing the chiral beta-amido phosphorus-sulfur compound with the metal complex shown in the formula I. The preparation method simplifies the operation flow in the production process, has low requirement on reaction conditions, is safe and controllable in the reaction process, high in atom utilization rate and production efficiency and low in environmental pollution pressure, and therefore, the preparation method obviously reduces the production cost for preparing the complex of the chiral phosphorus-sulfur compound and the metal.
Detailed Description
In order to make the technical problems, technical solutions and advantageous effects to be solved by the present application more clearly apparent, the present application is further described in detail below with reference to the embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the present application and are not intended to limit the present application.
The compounds and derivatives thereof referred to in the examples of the present invention are named according to the IUPAC (International Union of pure and applied chemistry) or CAS (chemical abstracts service, Columbus, Ohio) naming system. Accordingly, the groups of compounds specifically referred to in the examples of the present invention are illustrated and described as follows:
"alkoxy" refers to a straight or branched chain saturated aliphatic chain bonded to an oxygen atom, including, but not limited to, methoxy, ethoxy, propoxy, butoxy, isobutoxy, t-butoxy, and the like. (C)a-Cb) Alkoxy means any straight or branched, monovalent, saturated aliphatic chain in which an alkyl group containing "a" to "b" carbon atoms is bonded to an oxygen atom.
"alkyl" refers to a straight or branched chain saturated aliphatic chain, including but not limited to, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, hexyl, and the like.
"heteroalkyl" means a saturated aliphatic chain, straight or branched, containing at least one heteroatom linkage, such as, but not limited to, methylaminoethyl, methyloxypropyl, or other similar groups.
"alkenyl" refers to straight or branched chain hydrocarbons having one or more double bonds, including but not limited to, groups such as ethenyl, propenyl, and the like.
"Heteroalkenyl" means a straight or branched chain hydrocarbon with one or more double bonds containing at least one heteroatom linkage, including but not limited to, for example, vinylaminoethyl or other similar groups.
"alkynyl" refers to a straight or branched chain hydrocarbon with one or more triple bonds, including but not limited to, for example, ethynyl, propynyl, and the like.
"Heteroalkynyl" refers to a straight or branched chain hydrocarbon with one or more triple bonds containing at least one heteroatom linkage.
"aryl" refers to a cyclic aromatic hydrocarbon, which may be a monocyclic or polycyclic or fused ring aromatic hydrocarbon, including but not limited to, for example, phenyl, naphthyl, anthryl, phenanthryl, and the like.
"heteroaryl" means a monocyclic or polycyclic or fused ring aromatic hydrocarbon in which one or more carbon atoms have been replaced with a heteroatom such as nitrogen, oxygen, or sulfur. If the heteroaryl group contains more than one heteroatom, these heteroatoms may be the same or different. Heteroaryl groups include, but are not limited to, groups such as benzofuranyl, benzothienyl, benzimidazolyl, benzoxazolyl, benzothiazolyl, benzopyranyl, furanyl, imidazolyl, indazolyl, indolizinyl, indolyl, isobenzofuranyl, isoindolyl, isoquinolyl, isothiazolyl, isoxazolyl, naphthyridinyl, oxadiazolyl, oxazinyl, oxazolyl, phthalazinyl, pteridinyl, purinyl, pyranyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridine [3,4-b ] indolyl, pyridyl, pyrimidinyl, pyrrolyl, quinolizinyl, quinolyl, quinoxalinyl, thiadiazolyl, thiatriazolyl, thiazolyl, thienyl, triazinyl, triazolyl, xanthenyl, and the like.
"cycloalkyl" refers to a saturated monocyclic or polycyclic alkyl group, possibly fused to an aromatic hydrocarbon group. Cycloalkyl groups include, but are not limited to, groups such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, indanyl, tetrahydronaphthyl, and the like.
"Heterocycloalkyl" means a saturated monocyclic or polycyclic alkyl group in which at least one carbon atom has been replaced by a heteroatom such as nitrogen, oxygen or sulfur, possibly fused to an aromatic hydrocarbon group. If the heterocycloalkyl group contains more than one heteroatom, these heteroatoms may be the same or different. Heterocycloalkyl groups include, but are not limited to, groups such as azepanyl, azetidinyl, indolinyl, morpholinyl, pyrazinyl, piperidinyl, pyrrolidinyl, tetrahydrofuryl, tetrahydroquinolinyl, tetrahydroindazolyl, tetrahydroindolyl, tetrahydroisoquinolinyl, tetrahydropyranyl, tetrahydroquinoxalinyl, tetrahydrothiopyranyl, thiazolidinyl, thiomorpholinyl, thioxanthyl, and the like.
"cycloalkenyl" refers to an unsaturated monocyclic or polycyclic alkenyl group with one or more double bonds, possibly fused to an aromatic hydrocarbon group, including but not limited to, cyclic ethenyl, cyclopropenyl, or other similar groups.
"Heterocycloalkenyl" means an unsaturated monocyclic or polycyclic alkenyl group with one or more double bonds, wherein at least one carbon atom is replaced by a heteroatom such as nitrogen, oxygen or sulfur, possibly fused to an aromatic hydrocarbon group. If the heterocycloalkyl group contains more than one heteroatom, these heteroatoms may be the same or different.
"cycloalkynyl" refers to an unsaturated monocyclic or polycyclic alkynyl group with one or more triple bonds, possibly fused to an aromatic hydrocarbon group, including, but not limited to, cycloalkynyl, cyclopropynyl, or other like groups.
"Heterocycloalkynyl" means an unsaturated monocyclic or polycyclic alkynyl group having one or more triple bonds in which at least one carbon atom is replaced by a heteroatom such as nitrogen, oxygen or sulfur, possibly fused to an aromatic hydrocarbon group. If a heterocyclic alkynyl group contains more than one heteroatom, these heteroatoms may be the same or different.
The hetero atom may be an oxygen atom, a nitrogen atom, a sulfur atom or the like.
In one aspect, embodiments of the present invention provide a metal complex, where a molecular structural general formula of the metal complex is as shown in formula i:
Figure BDA0002787250550000061
wherein the content of the first and second substances,
R1、R2、R3and R5Are identical or different C1-C20Alkyl radical, C1-C20Heteroalkyl group, C3-C20Cycloalkyl radical, C3-C20Heterocycloalkyl radical, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C3-C20Cycloalkenyl radical, C3-C20Heterocycloalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, C3-C20Cycloalkynyl group, C3-C20Heterocycloalkynyl, C1-C20Alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, heteroaryloxy, aryl (C)1-C20) Alkyl, heteroaryl (C)1-C20) Alkyl radical, C2-C20Alkenyl (C)1-C20) Alkyl radical, C2-C20Alkynyl (C)1-C20) Alkyl, cyano (C)1-C20) Alkyl and C1-C20Alkyloxycarbonyl (C)1-C20) Any one of alkyl groups;
R4is hydrogen atom, cyano, C1-C20Ester group, C1-C20Alkyl radical, C1-C20Heteroalkyl group, C1-C20Haloalkyl, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, aryl (C)1-C20) Alkyl radical, C2-C10Alkenyl (C)1-C20) Alkyl and C2-C10Alkynyl (C)1-C20) Any one of alkyl groups;
R6is a halogen atom, C1-C5Ester group, C1-C5Borate ester group, C1-C5Phosphate group and C1-C5Any one of sulfonate groups;
m is any one of palladium, iridium, rhodium, manganese, nickel, platinum, gold, lithium and copper.
The metal complex provided by the application is a complex of a chiral phosphorus-sulfur compound and a metal, has a typical high-functional group structure, such as a chiral quaternary carbon atom containing an electron-withdrawing group and an amino group, has a classical organic metal complex structure, widens the coordination of the phosphorus-sulfur compound, can expand organic asymmetric catalytic reaction, and has good application in the synthesis of a drug intermediate and the preparation of a functional material.
R1、R2、R3And R5Are identical or different C1-C20Alkyl radical, C1-C20Heteroalkyl group, C3-C20Cycloalkyl radical, C3-C20Heterocycloalkyl radical, C2-C20An alkenyl group,C2-C20Heteroalkenyl, C3-C20Cycloalkenyl radical, C3-C20Heterocycloalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, C3-C20Cycloalkynyl group, C3-C20Heterocycloalkynyl, C1-C20Alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, heteroaryloxy, aryl (C)1-C20) Alkyl, heteroaryl (C)1-C20) Alkyl radical, C2-C20Alkenyl (C)1-C20) Alkyl radical, C2-C20Alkynyl (C)1-C20) Alkyl, cyano (C)1-C20) Alkyl and C1-C20Alkyloxycarbonyl (C)1-C20) Any one of the alkyl radicals is R1、R2、R3And R5Each independently selected from the above groups, and may be the same or different.
When R is1、R2、R3Or R5Is selected from C1-C20When it is an alkyl group, in one embodiment, the group (C)1-C20) The alkyl group may be (C)1-C10) Alkyl, (C)1-C5) Alkyl, (C)1-C4) Alkyl, (C)1-C3) Alkyl, (C)1-C2) Alkyl groups, and the like. In certain embodiments, (C)1-C20) The alkyl group may be methyl, ethyl, propyl, butyl, isobutyl, pentyl, isopentyl, and the like.
When R is1、R2、R3Or R5Is selected from (C)1-C20) When it is heteroalkyl, in one embodiment, (C) is1-C20) The heteroalkyl group may be (C)1-C10) Heteroalkyl group, (C)2-C5) Heteroalkyl group, (C)3-C4) Heteroalkyl groups and the like. In certain embodiments, the heteroatom may be an atom, a nitrogen atom, a sulfur atom, and the like.
When R is1、R2、R3Or R5Is selected from (C)3-C20) Cycloalkyl, in one embodiment, the (C)3-C20) The cycloalkyl group may be (C)3-C10) Cycloalkyl group, (C)3-C5) Cycloalkyl group, (C)3-C4) Cycloalkyl groups, and the like. In certain embodiments, (C)3-C20) Cycloalkyl groups may be cyclopropyl, cyclobutyl, cyclopentyl, and the like.
When R is1、R2、R3Or R5Is selected from (C)3-C20) When it is heterocycloalkyl, in one embodiment, (C) is3-C20) The heterocycloalkyl group may be (C)3-C10) Heterocycloalkyl group, (C)3-C10) Heterocycloalkyl group, (C)3-C5) Heterocycloalkyl group, (C)3-C4) Heterocycloalkyl, and the like. In certain embodiments, the heteroatom may be an oxygen atom, a nitrogen atom, a sulfur atom, and the like.
When R is1、R2、R3Or R5Is selected from (C)2-C20) Alkenyl, in one embodiment, the (C)2-C20) The alkenyl group may be (C)3-C10) Alkenyl, (C)3-C5) Alkenyl, (C)3-C4) Alkenyl, (C)2-C3) Alkenyl groups, and the like. In certain embodiments, (C)2-C20) The alkenyl group may be ethenyl, propenyl, butenyl, pentenyl, etc.
When R is1、R2、R3Or R5Is selected from (C)2-C20) (iii) when heteroalkenyl, in one embodiment, the (C)2-C20) The heteroalkenyl group can be (C)2-C10) Heteroalkenyl, (C)3-C10) Heteroalkenyl, (C)3-C5) Heteroalkenyl and the like. In certain embodiments, the heteroatom may be a halogen, nitrogen atom, sulfur atom, or the like.
When R is1、R2、R3Or R5Is selected from (C)3-C20) Cycloalkenyl group, in one embodiment, the (C)3-C20) Cycloalkenyl can be (C)3-C10) Cycloalkenyl group, (C)3-C5) Cycloalkenyl group, (C)3-C4) Cycloalkenyl groups, and the like. In certain embodiments, (C)3-C20) Cycloalkenyl can be cyclopropenyl, cyclobutenyl, cyclopentenyl and the like.
When R is1、R2、R3Or R5Is selected from (C)3-C20) When heterocycloalkenyl is present, in one embodiment, (C) is3-C20) The heterocycloalkenyl group may be (C)3-C10) Heterocycloalkenyl, (C)3-C5) Heterocycloalkenyl, (C)3-C4) Heterocycloalkenyl, and the like. In certain embodiments, the heteroatom may be a halogen, nitrogen atom, sulfur atom, or the like.
When R is1、R2、R3Or R5Is selected from (C)2-C20) Alkynyl, in one embodiment, (C)2-C20) Alkynyl may be (C)2-C10) Alkynyl, (C)3-C10) Alkynyl, (C)3-C5) Alkynyl, (C)3-C4) Alkynyl, (C)2-C3) Alkynyl and the like. In certain embodiments, (C)2-C20) The alkynyl group may be an ethynyl group, propynyl group, butynyl group, pentynyl group or the like.
When R is1、R2、R3Or R5Is selected from (C)2-C20) When heteroalkynyl is present, in one embodiment, (C) is2-C20) The heteroalkynyl can be (C)2-C10) Heteroalkynyl, (C)3-C10) Heteroalkynyl, (C)3-C5) Heteroalkynyl, (C)3-C4) Heteroalkynyl, and the like. In certain embodiments, the heteroatom may be a halogen, nitrogen atom, sulfur atom, or the like.
When R is1、R2、R3Or R5Is selected from (C)3-C20) When cycloalkynyl is present, in one embodiment, (C) is3-C20) The cycloalkynyl group can be (C)3-C10) Cycloalkynyl, (C)3-C5) Cycloalkynyl, (C)3-C4) Cycloalkynyl, and the like. In certain embodiments, (C)2-C20) Cycloalkynyl may beAnd cyclopropynyl, cyclobutynyl, cyclopentynyl and the like.
When R is1、R2、R3Or R5Is selected from (C)3-C20) When heterocycloalkynyl is present, in one embodiment, (C) is3-C20) The heterocycloalkynyl can be (C)3-C10) Heterocycloalkynyl, (C)3-C5) Heterocycloalkynyl, (C)3-C4) Heterocycloalkynyl, and the like. In certain embodiments, the heteroatom may be a halogen, nitrogen atom, sulfur atom, or the like.
When R is1、R2、R3Or R5Is selected from (C)1-C20) Alkoxy, in one embodiment, the (C)1-C20) The alkoxy group may be (C)1-C10) Alkoxy group, (C)1-C8) Alkoxy group, (C)1-C6) Alkoxy group, (C)1-C4) Alkoxy group, (C)1-C3) Alkoxy group, (C)1-C2) An alkoxy group. In certain embodiments, this (C)1-C20) Alkoxy groups may be, but are not limited to, methyloxy, ethyloxy, propyloxy, and the like.
When R is1、R2、R3Or R5When selected from aryl, the aryl group can be, but is not limited to, monocyclic aryl, polycyclic aryl, fused ring aryl. In one embodiment, the aryl group is a monocyclic aryl group. In certain embodiments, the aryl group may be C4-C14Aryl groups such as phenyl, naphthyl, fluorenyl, anthracenyl, phenanthrenyl, and the like.
When R is1、R2、R3Or R5When selected from substituted aryl groups, the substituted aryl groups may be, but are not limited to, phenyl groups substituted singly or multiply in the ortho, meta, or para positions. Substituents include, but are not limited to, alkyl, substituted alkyl, aryl, substituted aryl, acyl, halo, alkoxy, nitro, -NR9R10、-NR9-CO-NR10、-OCONR9、-PR9R10、-SOR9、-SO2-R9、-SiR9R10R11、-BR9R10Wherein R is9、R10、R11R as defined above, which may be the same or different1、R2The groups shown. Wherein, when the substituent is an alkyl group, the alkyl group is exemplified by, but not limited to, methyl, ethyl, propyl, butyl, isobutyl; when the substituent is a substituted alkyl group, such as, but not limited to, trifluoromethyl, trichloromethyl, pentafluoroethyl, pentachloroethyl; when the substituent is halogen, such as, but not limited to, fluorine, chlorine, bromine, iodine; when the substituent is an alkoxy group, the alkoxy group is, for example, but not limited to, methyloxy, ethyloxy, propyloxy. In one embodiment, the substituted aryl group may be substituted (C)4-C14) Aryl, e.g. being cyano (C)1-C10) Alkyl radical (C)4-C8) Aryl, substituted (C)4-C8) And (4) an aryl group.
When R is1、R2、R3Or R5When selected from heteroaryl, in one embodiment, the heteroaryl may be (C)4-C14) Heteroaryl groups such as thienyl, thiazolyl, pyrrolyl, pyrazinyl, pyridyl, benzothiophene, and the like.
When R is1、R2、R3Or R5When selected from substituted heteroaryl, in one embodiment, the substituted heteroaryl may be substituted (C)4-C14) Heteroaryl, e.g. alkoxy-substituted furans, (C)3-C8) Heteroaryl substituted furans, aliphatic chain substituted thiophenes, and the like.
When R is1、R2、R3Or R5When selected from aryloxy, in one embodiment, the aryloxy may be C4-C14Aryloxy groups such as phenoxy, naphthoxy, anthracenoxy, phenanthrenoxy and the like.
When R is1、R2、R3Or R5When selected from heteroaryloxy, in one embodiment, the heteroaryloxy group may be C4-C14A heteroaryloxy group.
When R is1、R2、R3Or R5Selected from aryl (C)1-C20) When it is an alkyl group, in one embodiment, the aryl group (C)1-C20) The alkyl group may be C4-C14Aryl radical (C)1-C10) Alkyl radicals, e.g. phenyl (C)1-C10) Alkyl, phenyl (C)1-C5) Alkyl, phenyl (C)1-C4) Alkyl, phenyl (C)1-C3) Alkyl, phenyl (C)1-C2) Alkyl groups, and the like. In certain embodiments, aryl (C)1-C20) The alkyl group may be phenylmethyl, phenylethyl, phenylpropyl, phenylbutyl, phenylisobutyl, phenylpentyl, phenylisopentyl, phenylneopentyl, and the like.
When R is1、R2、R3Or R5Is selected from heteroaryl (C)1-C20) When alkyl, in one embodiment, the heteroaryl (C)1-C20) The alkyl group may be C4-C14Heteroaryl (C)1-C10) Alkyl radicals, e.g. heteroaryl (C)1-C10) Alkyl, heteroaryl (C)1-C5) Alkyl, heteroaryl (C)1-C4) Alkyl, heteroaryl (C)1-C3) Alkyl, heteroaryl (C)1-C2) Alkyl groups, and the like.
When R is1、R2、R3Or R5Is selected from (C)2-C20) Alkenyl (C)1-C20) When it is an alkyl group, in one embodiment, the group (C)2-C20) Alkenyl (C)1-C20) The alkyl group may be (C)2-C10) Alkenyl (C)1-C10) Alkyl, (C)2-C5) Alkenyl (C)1-C3) Alkyl groups, and the like.
When R is1、R2、R3Or R5Is selected from (C)2-C20) Alkynyl (C)1-C20) When it is an alkyl group, in one embodiment, the group (C)2-C20) Alkynyl (C)1-C20) The alkyl group may be (C)2-C10) Alkynyl (C)1-C10) Alkyl, (C)2-C5) Alkynyl (C)1-C3) Alkyl radicalAnd the like.
When R is1、R2、R3Or R5Is selected from cyano (C)1-C20) Alkyl, in one embodiment, the cyano (C)1-C20) The alkyl group may be cyano (C)1-C10) Alkyl, cyano (C)1-C5) Alkyl, cyano (C)1-C4) Alkyl, cyano (C)1-C3) Alkyl, cyano (C)1-C2) Alkyl groups, and the like. In certain embodiments, cyano (C)1-C20) The alkyl group may be cyanomethyl, cyanoethyl, cyanopropyl, cyanobutyl, cyanopentyl, or the like.
When R is1、R2、R3Or R5Is selected from C1-C20Alkyl oxycarbonyl (C)1-C20) When it is alkyl, in one embodiment, the C1-C20Alkyl oxycarbonyl (C)1-C20) The alkyl group may be (C)1-C10) Alkyl oxycarbonyl (C)1-C10) Alkyl, (C)1-C5) Alkyl oxycarbonyl (C)1-C5) Alkyl, (C)1-C4) Alkyl oxycarbonyl (C)1-C4) Alkyl groups, and the like.
R4Is hydrogen atom, cyano, C1-C20Ester group, C1-C20Alkyl radical, C1-C20Heteroalkyl group, C1-C20Haloalkyl, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, aryl (C)1-C20) Alkyl radical, C2-C10Alkenyl (C)1-C20) Alkyl and C2-C10Alkynyl (C)1-C20) Any one of alkyl groups; further, R4Is a hydrogen atom, C1-C5Ester group, C1-C5Perhaloalkyl and C2-C10Any one of heteroalkyl groups. R4And R3Are not identical.
R6Is a halogen atomSeed, C1-C5Ester group, C1-C5Borate ester group, C1-C5Phosphate group and C1-C5Any one of sulfonate groups; further, R6Is a halogen atom.
M is any one of palladium, iridium, rhodium, manganese, nickel, platinum, gold, lithium and copper.
In one embodiment, in the metal complex of formula I, R5Is heteroaryl, specifically shown in the following structure, and X is a heteroatom, such as nitrogen atom, sulfur atom, oxygen atom, and the like.
Figure BDA0002787250550000111
The metal complex not only widens the coordination of phosphorus-sulfur compounds, but also constructs a chiral metal complex with potential by utilizing the coordination of amide and hetero atoms.
Specifically, in the metal complex, R1、R2And R3Is any one of aryl and substituted aryl which are the same or different, R4Is C1-C20Haloalkyl, R5Is heteroaryl, R6Is a halogen atom, C1-C5Ester group, C1-C5Borate ester group, C1-C5Phosphate group and C1-C5Any one of sulfonate groups. Wherein, R is1、R2And R3Wherein, the aryl group is selected from at least one of phenyl, naphthyl, anthryl, phenanthryl and fluorenyl, the substituted aryl group is selected from at least one of substituted phenyl, substituted naphthyl, substituted anthryl, substituted phenanthryl and substituted fluorenyl, and the R is5Is a nitrogen atom-containing heteroaryl group. In the substituted aryl group, the substituent is selected from the group consisting of a halogen atom, a hydroxyl group, an amino group, a nitro group, a sulfo group, a cyano group, an acyl group, an ester group and (C)1-C10) Alkyl, (C)6-C14) Aryl and (C)4-C14) At least one heteroaryl group. When R is4Is C1-C20When halogenated with alkylIn one embodiment, the (C)1-C20) The haloalkyl group may be halo (C)1-C10) Alkyl radicals, e.g. monohalogenated C1-C3Alkyl, dihalo C1-C3Alkyl, trihalo C1-C3The alkyl group, wherein the halogen may be fluorine substituted, chlorine substituted, bromine substituted or iodine substituted, etc. For example, perfluoroalkyl groups such as trifluoromethyl, pentafluoroethyl, heptafluoropropyl, heptafluoroisopropyl, and the like may be mentioned.
Further, in the metal complex, R1Is (C)1-C5) Alkyl-substituted phenyl, R2Is (C)1-C5) Alkyl-substituted phenyl, R3Is phenyl, R4Is C1-C5Perhaloalkyl radical, R5Is pyridine, R6Is a halogen atom.
In a preferred embodiment, the metal complex has a skeleton containing biocompatible groups such as amide, trifluoromethyl and the like, so that a complex of a chiral phosphorus-sulfur compound with potential application and a metal is obtained, and the designability and application prospect of the compound are greatly expanded.
Figure BDA0002787250550000121
In another aspect, a process for preparing a metal complex as hereinbefore described, which process comprises the steps of:
s01: providing a chiral beta-nitro phosphorus sulfur compound A and a carboxylic acid compound B;
s02: adding the chiral beta-nitro-phosphorus-sulfur compound A into a reaction system containing reducing metal, hydrochloric acid or trimethylchlorosilane for reaction to obtain a chiral beta-amino-phosphorus-sulfur compound C;
s03: adding the chiral beta-aminophosphonium sulfur compound C into a reaction system containing the carboxylic acid compound B, a condensing agent and an alkali reagent to react to obtain a chiral beta-amidophosphorothioic compound ligand D;
s04: sulfurizing the chiral beta-phosphoramidateAddition of Complex ligand D to Metal-containing Compound MR6Reacting in the reaction system to obtain a metal complex shown as a formula I;
the structural general formula of the compound is as follows:
Figure BDA0002787250550000122
Figure BDA0002787250550000131
wherein the content of the first and second substances,
R1、R2、R3and R5Are identical or different C1-C20Alkyl radical, C1-C20Heteroalkyl group, C3-C20Cycloalkyl radical, C3-C20Heterocycloalkyl radical, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C3-C20Cycloalkenyl radical, C3-C20Heterocycloalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, C3-C20Cycloalkynyl group, C3-C20Heterocycloalkynyl, C1-C20Alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, heteroaryloxy, aryl (C)1-C20) Alkyl, heteroaryl (C)1-C20) Alkyl radical, C2-C20Alkenyl (C)1-C20) Alkyl radical, C2-C20Alkynyl (C)1-C20) Alkyl, cyano (C)1-C20) Alkyl and C1-C20Alkyloxycarbonyl (C)1-C20) Any one of alkyl groups;
R4is hydrogen atom, cyano, C1-C20Ester group, C1-C20Alkyl radical, C1-C20Heteroalkyl group, C1-C20Haloalkyl, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, aryl (C)1-C20) Alkyl radical, C2-C10Alkenyl (C)1-C20) Alkyl and C2-C10Alkynyl (C)1-C20) Any one of alkyl groups;
R6is a halogen atom, C1-C5Ester group, C1-C5Borate ester group, C1-C5Phosphate group and C1-C5Any one of sulfonate groups;
m is any one of palladium, iridium, rhodium, manganese, nickel, platinum, gold, lithium and copper.
The preparation method of the metal complex is a complex preparation method of a chiral phosphorus-sulfur compound and a metal complex, and comprises the steps of reducing a chiral beta-nitro phosphorus-sulfur compound A to obtain a chiral beta-amino phosphorus-sulfur compound C, condensing the chiral beta-amino phosphorus-sulfur compound C with a carboxylic acid compound B to obtain a chiral beta-amido phosphorus-sulfur compound ligand D, and finally complexing the chiral beta-amido phosphorus-sulfur compound with the metal complex shown in the formula I. The preparation method simplifies the operation flow in the production process, has low requirement on reaction conditions, is safe and controllable in the reaction process, high in atom utilization rate and production efficiency and low in environmental pollution pressure, and therefore, the preparation method obviously reduces the production cost for preparing the complex of the chiral phosphorus-sulfur compound and the metal.
In the step S01, the chiral β -nitrophosulfur compound a and the carboxylic acid compound B can be prepared according to a conventional method in the art, and can be obtained directly from the market.
For chiral beta-nitro phosphorus sulfur compound A and carboxylic acid compound B, and metal compound MR6In (b) each R1、R2、R3、R4、R5And R6In order to correspond to R in the finally obtained metal complex shown as the formula I1、R2、R3、R4、R5And R6R is a hydrogen atom1、R2、R3、R4、R5And R6Specific choices have been set forth above in detail.
In the above step S02 and step S03, the molar ratio of the chiral β -nitrophosphorus sulfide compound a to the carboxylic acid compound B is (0.1-20): (0.1-20). Specifically, the molar ratio of the chiral beta-nitro phosphorus sulfur compound A, the carboxylic acid compound B, the beta-amino phosphorus sulfur compound C and the chiral beta-amido phosphorus sulfur compound ligand D is (0.1-20): (0.1-20): (0.2-40): (1-100).
Further, the chiral beta-nitro-phosphorus-sulfur compound A is added into a reaction system containing reducing metal, hydrochloric acid or trimethylchlorosilane, and the reaction temperature is 50-100 ℃. Adding the chiral beta-aminophosphonium sulfur compound C into a reaction system containing the carboxylic acid compound B, the condensing agent and the alkali reagent to react at the temperature of 25-100 ℃.
Further, the carboxylic acid compound B is:
Figure BDA0002787250550000141
the obtained chiral beta-amidophosphoric sulfur compound ligand D is as follows:
Figure BDA0002787250550000142
the metal complex finally prepared is:
Figure BDA0002787250550000143
further, the reducing metal is selected from at least one of iron powder, zinc powder and manganese powder: the condensing agent is selected from at least one of 2- (7-azobenzotriazol) -N, N, N ', N' -tetramethylurea hexafluorophosphate, benzotriazol-N, N, N ', N' -tetramethylurea hexafluorophosphate, dicyclohexylcarbodiimide and 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride; the alkali reagent is at least one of lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, sodium phosphate, sodium hydrogen phosphate, sodium dihydrogen phosphate, potassium hydrogen phosphate, potassium dihydrogen phosphate, 1, 8-diazabicyclo [5.4.0] undec-7-ene, 1,5, 7-triazabicyclo (4.4.0) dec-5-ene, triethylamine, diisopropylethylamine, bistrimethylsilyl amino lithium, bistrimethylsilyl sodium, bistrimethylsilyl potassium, diisopropylamino lithium, n-butyl lithium, tert-butyl lithium, methyllithium, sodium methoxide, sodium ethoxide and sodium ethylmercaptide.
In the above step S04, the chiral beta-phosphoramidothio compound ligand D is added into the metal compound MR6The reaction temperature in the reaction system of (1) is 25 to 100 ℃.
Further, the metal compound MR6Is at least one of palladium dichloride, palladium acetate, tris (dibenzylideneacetone) dipalladium, tetrakis (triphenylphosphine) palladium, bis (1, 5-cyclooctadiene) iridium tetrafluoroborate, 1, 5-cyclooctadiene iridium chloride dimer, bis (1, 5-cyclooctadiene) rhodium tetrafluoroborate, (1, 5-cyclooctadiene) rhodium chloride dimer, polymeric rhodium dicarbonyl chloride, manganese pentacarbonyl bromide, manganese pentacarbonyl chloride, bis- (1, 5-cyclooctadiene) nickel, nickel chloride, (1, 5-cyclooctadiene) platinum diiodide, (1, 5-cyclooctadiene) platinum dichloride, gold chloride, gold chlorite, copper dichloride, copper sulfate, ketone tetrafluoroborate, ketone hexafluorophosphate and lithium chloride.
In a word, the preparation method of the complex of the chiral phosphorus-sulfur compound and the metal is implemented by the steps of reducing, condensing, complexing with the metal and the like of the chiral beta-nitro phosphorus-sulfur compound; the preparation method has the advantages of simple process, low requirement on reaction conditions, safe and controllable reaction process, high atom utilization rate and production efficiency, and high efficiency in ensuring the enantioselectivity of the product. And the operation flow in the preparation and production process is simplified, the toxicity of the reaction residues is reduced to the minimum, the pollution to the environment in the production process is reduced, and the steps and the operation for removing the residues after the reaction can be simplified. In addition, reactant raw materials are very easy to obtain, and the reactants can be directly used for preparation production without additional modification before reaction, so that the operation steps are simplified, and the reaction route is shortened; obviously reduces the production cost. The preparation method for constructing the complex of the chiral phosphorus-sulfur compound and the metal can be widely applied to the research fields of organic synthetic chemistry, biochemistry, asymmetric catalysis, pesticides and medicines. The complex of the chiral phosphorus-sulfur compound and the metal complex has good application in the synthesis of a drug intermediate, the preparation of a functional material and a metal ligand or a complex, and can effectively reduce the economic cost for the preparation of the drug intermediate, the functional material and the metal ligand or the complex.
The following description will be given with reference to specific examples.
Example 1
Respectively providing a nitro phosphorus sulfur compound A1 and a carboxylic acid compound B1 represented by the following structural formulas to prepare a complex of a chiral phosphorus sulfur compound and a metal:
A1、
Figure BDA0002787250550000161
B1、
Figure BDA0002787250550000162
(1) preparation of beta-aminophosphonium sulphur compounds
The nitro phosphorus sulfur compound A1(0.1mmol) and zinc powder (0.7mmol) were dissolved in a mixed solvent of 0.6mL of methanol, 0.3mL of tetrahydrofuran and 0.6mL of hydrochloric acid (6M), and the mixture was refluxed at 80 ℃ and stirred overnight. The progress of the reaction was checked by TLC, when the reaction was complete, saturated aqueous sodium bicarbonate was slowly added dropwise to adjust the pH of the solution to 8, the solution was filtered through celite and extracted twice with dichloromethane, the combined organic phases were dried over anhydrous sodium sulfate for 1 hour and filtered, the organic phase was concentrated and then directly purified by silica gel column chromatography (methanol and dichloromethane as eluent) to give β -aminophosphazene compound C1, i.e. (S) - (3-amino-1, 1, 1-trifluoro-2-phenylpropan-2-yl) di-p-tolyl phosphorothioide in 77% yield and 95% ee. The structural formula of the (S) - (3-amino-1, 1, 1-trifluoro-2-phenylpropan-2-yl) di-p-tolyl phosphorus sulfide compound is shown as the following molecular structural formula C1:
Figure BDA0002787250550000163
the prepared beta-aminophosphonium sulfur compound C1 was subjected to characterization data analysis, and the results were:1H NMR(400MHz,CDCl3)δ7.82(dd,J=12.6,8.1Hz,2H),7.58–7.49(m,2H),7.36–7.30(m,1H),7.30–7.25(m,2H),7.24–7.18(m,4H),7.08(dd,J=8.3,3.2Hz,2H),3.83(dd,J=5.6,3.3Hz,2H),2.39(s,3H),2.33(s,3H),1.33(s,2H).13C NMR(101MHz,CDCl3)δ142.66(d,J=3.0Hz),142.45(d,J=3.0Hz),134.25(d,J=10.1Hz),133.87(d,J=9.1Hz),130.45(q,J=6.1Hz),130.17(d,J=5.1Hz),128.84,128.65(q,J=286.8Hz),128.52,128.20(d,J=3.0Hz),126.30(d,J=12.1Hz),125.49(d,J=18.2Hz),93.01,44.26(q,J=25.1Hz),29.82,21.55(d,J=2.0Hz),21.47(d,J=1.0Hz).31P NMR(162MHz,CDCl3)δ50.46.HRMS(ESI-TOF)[M+H]calculated for[C23H24F3NPS]+434.1319, applied 434.1315.HPLC (Chiralpak-IC-H column,80:20hexane/ethanol, flow rate:1.0mL/min): tmajor 9.679 min; tminor 18.555 min; this result further confirmed the molecular structure of the product as described above for molecular structure C1.
(2) Preparation of beta-phosphorothioates
The β -aminophosphothio compound C1(0.1mmol) was dissolved in 1.0mL of pretreated dichloromethane, and carboxylic acid compound B1, i.e., 2-picolinic acid (0.11mmol), 2- (7-azobenzotriazol) -N, N' -tetramethyluronium hexafluorophosphate (0.1mmol), and nitrogen, nitrogen-diisopropylethylamine (0.3mmol) were added thereto at room temperature, followed by stirring at room temperature overnight. The reaction was then quenched with water, the aqueous phase was extracted twice with dichloromethane, the combined organic phases were dried over anhydrous sodium sulfate for 1 hour and filtered, and the organic phase was concentrated and then directly purified by column chromatography on silica gel (ethyl acetate and petroleum ether as eluent) to give the β -phosphothioate compound D1, i.e. (S) -nitrogen- (2- (di-p-tolylthio-thiophosphate) -3,3, 3-trifluoro-2-phenylpropyl) pyridinamide in 84% yield and 94% ee. The structural formula of the (S) -N- (2- (di-p-tolyl thiophosphoryl) -3,3, 3-trifluoro-2-phenylpropyl) pyridinamide is shown as the following molecular structural formula D1:
Figure BDA0002787250550000171
the prepared beta-aminoacyl phosphorus sulfur compound D1 is analyzed by characterization data, and the result is that:1H NMR(400MHz,CDCl3)δ8.35(d,J=4.4Hz,1H),8.31–8.24(m,1H),8.04(d,J=7.8Hz,1H),7.85(dd,J=12.7,8.2Hz,1H),7.70(m,J=7.7,1.5Hz,1H),7.63(dd,J=12.3,8.2Hz,1H),7.28(dd,J=12.5,5.3Hz,1H),7.23–7.15(m,1H),7.12(dd,J=8.0,2.8Hz,1H),4.81(dd,J=13.5,7.3Hz,1H),4.53(dt,J=14.9,5.0Hz,1H),2.34(d,J=11.5Hz,1H).13C NMR(101MHz,CDCl3)δ164.27(s),149.27(s),148.23(s),142.89(d,J=3.2Hz),142.84(d,J=3.0Hz),137.30(s),134.32(d,J=10.4Hz),134.01(d,J=9.7Hz),130.22(s),129.90(d,J=3.8Hz),128.90(d,J=2.5Hz),128.77(d,J=2.2Hz),128.07(d,J=2.0Hz),126.33(s),126.26(s),125.49(d,J=4.8Hz),124.67(s),122.21(s),61.34(dd,J=38.3,21.8Hz),40.72(s),29.83(s),21.53(d,J=2.1Hz).31P NMR(162MHz,CDCl3)δ51.46(s).HRMS(ESI-TOF)[M+H]calculated for[C29H27N2OF3PS+]+539.1528,observed 539.1526.HPLC(Chiralpak-IC-H column,85:15hexane/ethanol,flow rate:1.0mL/min):tmajor=15.670 min;tminor17.472 min; this result further confirmed the molecular structure of the product as described above for molecular structure D1.
(3) Metal complex of chiral phosphorus-sulfur compound and metal
Dissolving palladium dichloride (0.23mmol) and lithium chloride (0.92mmol) in a mixed solvent (2: 1, 100mL) of methanol and trichloromethane, and stirring for 30 minutes at normal temperature; beta-aminoacyl phosphorus sulfide D1(0.23mmol) is dissolved in a mixed solvent of methanol and chloroform (2: 1, 5mL), and then is dropwise added into the reaction system, and stirring is continued for 5 days at normal temperature. After the reaction is finished, the reaction liquid is dried and concentrated under reduced pressure, and then is directly separated and purified by silica gel column chromatography (ethyl acetate and petroleum ether are used as eluent) to obtain the target product metal complex I1, namely (S) - (N- (2- (p-tolyl phosphorothioacyl) -3,3, 3-trifluoro-2-phenylpropyl) pyridine carboxamide group) palladium chloride, yellow solid, the yield is 63 percent, and the ee value is 94 percent. The structural formula of the (S) - (N- (2- (p-tolyl phosphorothioacyl) -3,3, 3-trifluoro-2-phenylpropyl) pyridine carboxamide) palladium chloride is shown as the following molecular structural formula I1:
Figure BDA0002787250550000181
the product I1 prepared was subjected to characterization data analysis, which resulted in:1H NMR(400MHz,CDCl3)δ9.03(d,J=5.4Hz,1H),8.21(dd,J=13.3,8.2Hz,1H),7.95(m,J=6.2Hz,1H),7.59(d,J=7.5Hz,1H),7.47–7.33(m,1H),7.28(dd,J=8.1,3.2Hz,1H),7.23(d,J=8.6Hz,1H),7.18(t,J=7.5Hz,1H),7.00(dd,J=8.1,3.5Hz,1H),4.84–4.31(m,1H),2.38(s,1H),2.26(s,1H).13C NMR(101MHz,CDCl3)δ153.87(s),147.77(s),144.50(d,J=3.2Hz),143.75(d,J=3.1Hz),139.81–139.13(m),134.42(d,J=11.1Hz),133.73(d,J=9.4Hz),131.61(s),129.71(s),129.57(s),129.39(s),129.26(s),128.60–128.38(m),126.76(s),125.84(s),123.91(s),123.16(s),122.30(s).31P NMR(162MHz,CDCl3)δ62.26(s).HRMS(ESI-TOF)[M-Cl]calculated for[C29H25F3N2OPPdS]+643.0412,observed 643.0408.HPLC(Chiralpak-IC-H column,80:20 hexane/ethanol,flow rate:1.0mL/min):tmajor=32.542min;tminor29.478 min; this result further confirmed the molecular structure of the product as described above for molecular structure I1.
The above description is only exemplary of the present application and should not be taken as limiting the present application, as any modification, equivalent replacement, or improvement made within the spirit and principle of the present application should be included in the protection scope of the present application.

Claims (10)

1. A metal complex is characterized in that the molecular structure general formula of the metal complex is shown as formula I:
Figure FDA0002787250540000011
wherein the content of the first and second substances,
R1、R2、R3and R5Are identical or different C1-C20Alkyl radical, C1-C20Heteroalkyl group, C3-C20CycloalkanesBase, C3-C20Heterocycloalkyl radical, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C3-C20Cycloalkenyl radical, C3-C20Heterocycloalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, C3-C20Cycloalkynyl group, C3-C20Heterocycloalkynyl, C1-C20Alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, heteroaryloxy, aryl (C)1-C20) Alkyl, heteroaryl (C)1-C20) Alkyl radical, C2-C20Alkenyl (C)1-C20) Alkyl radical, C2-C20Alkynyl (C)1-C20) Alkyl, cyano (C)1-C20) Alkyl and C1-C20Alkyloxycarbonyl (C)1-C20) Any one of alkyl groups;
R4is hydrogen atom, cyano, C1-C20Ester group, C1-C20Alkyl radical, C1-C20Heteroalkyl group, C1-C20Haloalkyl, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, aryl (C)1-C20) Alkyl radical, C2-C10Alkenyl (C)1-C20) Alkyl and C2-C10Alkynyl (C)1-C20) Any one of alkyl groups;
R6is a halogen atom, C1-C5Ester group, C1-C5Borate ester group, C1-C5Phosphate group and C1-C5Any one of sulfonate groups;
m is any one of palladium, iridium, rhodium, manganese, nickel, platinum, gold, lithium and copper.
2. The metal complex of claim 1, wherein R is1、R2、R3And R5Are identical or different C1-C10Alkyl radical, C1-C10Heteroalkyl group, C3-C10Cycloalkyl radical, C3-C10Heterocycloalkyl radical, C2-C10Alkenyl radical, C2-C10Heteroalkenyl, C3-C10Cycloalkenyl radical, C3-C10Heterocycloalkenyl, C2-C10Alkynyl, C2-C10Heteroalkynyl, C3-C10Cycloalkynyl group, C3-C10Heterocycloalkynyl, C1-C10Alkoxy radical, C4-C14Aryl, substituted (C)4-C14) Aryl radical, C4-C14Heteroaryl, substituted (C)4-C14) Heteroaryl group, C4-C14Aryloxy radical, C4-C14Heteroaryloxy radical, C4-C14Aryl radical (C)1-C10) Alkyl radical, C4-C14Heteroaryl (C)1-C10) Alkyl radical, C2-C10Alkenyl (C)1-C10) Alkyl radical, C2-C10Alkynyl (C)1-C10) Alkyl, cyano (C)1-C10) Alkyl and C1-C10Alkyloxycarbonyl (C)1-C10) Any one of alkyl groups; and/or the presence of a gas in the gas,
R4is a hydrogen atom, C1-C5Ester group, C1-C5Perhaloalkyl and C2-C10Any one of heteroalkyl groups; and/or the presence of a gas in the gas,
R6is a halogen atom.
3. The metal complex of claim 1, wherein R is1、R2And R3Is any one of aryl and substituted aryl which are the same or different, R4Is C1-C20Haloalkyl, R5Is heteroaryl.
4. The metal complex of claim 3, wherein R is1、R2And R3Wherein, the aryl group is selected from at least one of phenyl, naphthyl, anthryl, phenanthryl and fluorenyl, the substituted aryl group is selected from at least one of substituted phenyl, substituted naphthyl, substituted anthryl, substituted phenanthryl and substituted fluorenyl, and the R is5Is a nitrogen atom-containing heteroaryl group.
5. The metal complex according to claim 4, wherein the substituent of the substituted aryl group is selected from the group consisting of a halogen atom, a hydroxyl group, an amino group, a nitro group, a sulfo group, a cyano group, an acyl group, an ester group, and a group (C)1-C10) Alkyl, (C)6-C14) Aryl and (C)4-C14) At least one heteroaryl group.
6. The metal complex of claim 4, wherein R is1Is (C)1-C5) Alkyl-substituted phenyl, R2Is (C)1-C5) Alkyl-substituted phenyl, R3Is phenyl, R4Is C1-C5Perhaloalkyl radical, R5Is pyridine, R6Is a halogen atom.
7. A method for preparing a metal complex, comprising the steps of:
providing a chiral beta-nitro phosphorus sulfur compound A and a carboxylic acid compound B;
adding the chiral beta-nitro-phosphorus-sulfur compound A into a reaction system containing reducing metal, hydrochloric acid or trimethylchlorosilane for reaction to obtain a chiral beta-amino-phosphorus-sulfur compound C;
adding the chiral beta-aminophosphonium sulfur compound C into a reaction system containing the carboxylic acid compound B, a condensing agent and an alkali reagent to react to obtain a chiral beta-amidophosphorothioic compound ligand D;
adding the chiral beta-amidophosphorothioic compound ligand D into a metal compound MR6Reacting in the reaction system to obtain a metal complex shown as a formula I;
the structural general formula of the compound is as follows:
Figure FDA0002787250540000031
wherein the content of the first and second substances,
R1、R2、R3and R5Are identical or different C1-C20Alkyl radical, C1-C20Heteroalkyl group, C3-C20Cycloalkyl radical, C3-C20Heterocycloalkyl radical, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C3-C20Cycloalkenyl radical, C3-C20Heterocycloalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, C3-C20Cycloalkynyl group, C3-C20Heterocycloalkynyl, C1-C20Alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, heteroaryloxy, aryl (C)1-C20) Alkyl, heteroaryl (C)1-C20) Alkyl radical, C2-C20Alkenyl (C)1-C20) Alkyl radical, C2-C20Alkynyl (C)1-C20) Alkyl, cyano (C)1-C20) Alkyl and C1-C20Alkyloxycarbonyl (C)1-C20) Any one of alkyl groups;
R4is hydrogen atom, cyano, C1-C20Ester group, C1-C20Alkyl radical, C1-C20Heteroalkyl group, C1-C20Haloalkyl, C2-C20Alkenyl radical, C2-C20Heteroalkenyl, C2-C20Alkynyl, C2-C20Heteroalkynyl, aryl (C)1-C20) Alkyl radical, C2-C10Alkenyl (C)1-C20) Alkyl and C2-C10Alkynyl (C)1-C20) Any one of alkyl groups;
R6is a halogen atom, C1-C5Ester group, C1-C5Borate ester group, C1-C5Phosphate group and C1-C5Any one of sulfonate groups;
m is any one of palladium, iridium, rhodium, manganese, nickel, platinum, gold, lithium and copper.
8. The method according to claim 7, wherein the molar ratio of the chiral β -nitrophosulfur compound A to the carboxylic acid compound B is (0.1-20): (0.1-20).
9. The method of claim 7, wherein the reducing metal is selected from at least one of iron powder, zinc powder, and manganese powder: and/or
The condensing agent is selected from at least one of 2- (7-azobenzotriazol) -N, N, N ', N' -tetramethylurea hexafluorophosphate, benzotriazol-N, N, N ', N' -tetramethylurea hexafluorophosphate, dicyclohexylcarbodiimide and 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride; and/or
The alkali reagent is at least one of lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, sodium phosphate, sodium hydrogen phosphate, sodium dihydrogen phosphate, potassium hydrogen phosphate, potassium dihydrogen phosphate, 1, 8-diazabicyclo [5.4.0] undec-7-ene, 1,5, 7-triazabicyclo (4.4.0) dec-5-ene, triethylamine, diisopropylethylamine, bistrimethylsilyl amino lithium, bistrimethylsilyl sodium, bistrimethylsilyl potassium, diisopropylamino lithium, n-butyl lithium, tert-butyl lithium, methyllithium, sodium methoxide, sodium ethoxide and sodium ethylmercaptide; and/or
The metal compound MR6Is palladium dichloride, palladium acetate, tris (dibenzylideneacetone) dipalladium, tetrakis (triphenylphosphonium) palladium, bis (1, 5-cyclooctadiene) iridium tetrafluoroborate, 1, 5-cyclooctadiene iridium chloride dimer, bis (1, 5-cyclooctadiene) rhodium tetrafluoroborate, (1, 5-cyclooctadiene) rhodium chloride dimer, polymeric rhodium dicarbonyl chloride, manganese pentacarbonyl bromide, manganese pentacarbonyl chloride, bis- (1, 5-cyclooctadiene) nickelAt least one of nickel chloride, (1, 5-cyclooctadiene) platinum diiodide, (1, 5-cyclooctadiene) platinum dichloride, gold chloride, gold chlorite, copper dichloride, copper sulfate, ketone tetrafluoroborate, ketone hexafluorophosphate, and lithium chloride.
10. The method of claim 7, wherein R is1、R2、R3And R5Are identical or different C1-C10Alkyl radical, C1-C10Heteroalkyl group, C3-C10Cycloalkyl radical, C3-C10Heterocycloalkyl radical, C2-C10Alkenyl radical, C2-C10Heteroalkenyl, C3-C10Cycloalkenyl radical, C3-C10Heterocycloalkenyl, C2-C10Alkynyl, C2-C10Heteroalkynyl, C3-C10Cycloalkynyl group, C3-C10Heterocycloalkynyl, C1-C10Alkoxy radical, C4-C14Aryl, substituted (C)4-C14) Aryl radical, C4-C14Heteroaryl, substituted (C)4-C14) Heteroaryl group, C4-C14Aryloxy radical, C4-C14Heteroaryloxy radical, C4-C14Aryl radical (C)1-C10) Alkyl radical, C4-C14Heteroaryl (C)1-C10) Alkyl radical, C2-C10Alkenyl (C)1-C10) Alkyl radical, C2-C10Alkynyl (C)1-C10) Alkyl, cyano (C)1-C10) Alkyl and C1-C10Alkyloxycarbonyl (C)1-C10) Any one of alkyl groups; and/or the presence of a gas in the gas,
R4is a hydrogen atom, C1-C5Ester group, C1-C5Perhaloalkyl and C2-C10Any one of heteroalkyl groups; and/or the presence of a gas in the gas,
R6is a halogen atom.
CN202011302489.XA 2020-11-19 2020-11-19 Metal complex and preparation method thereof Pending CN112430249A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011302489.XA CN112430249A (en) 2020-11-19 2020-11-19 Metal complex and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011302489.XA CN112430249A (en) 2020-11-19 2020-11-19 Metal complex and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112430249A true CN112430249A (en) 2021-03-02

Family

ID=74694422

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011302489.XA Pending CN112430249A (en) 2020-11-19 2020-11-19 Metal complex and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112430249A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101020701A (en) * 2007-03-16 2007-08-22 郑州大学 Forcipated diimidazoline palladium compound and its application in Suzuki reaction
US20100292084A1 (en) * 2009-05-14 2010-11-18 Technion Research & Development Foundation Ltd. Novel diarylphosphine- and dialkylphosphine-containing compounds, processes of preparing same and uses thereof as tridentate ligands
CN104513274A (en) * 2013-09-29 2015-04-15 上海交通大学 P chiral pincer compound and palladium coordination compound thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101020701A (en) * 2007-03-16 2007-08-22 郑州大学 Forcipated diimidazoline palladium compound and its application in Suzuki reaction
US20100292084A1 (en) * 2009-05-14 2010-11-18 Technion Research & Development Foundation Ltd. Novel diarylphosphine- and dialkylphosphine-containing compounds, processes of preparing same and uses thereof as tridentate ligands
CN104513274A (en) * 2013-09-29 2015-04-15 上海交通大学 P chiral pincer compound and palladium coordination compound thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DIANA V. ALEKSANYAN ET AL.: "Synthesis and complexing properties of phosphorus-substituted pyridine-2-carboxylic acid anilides" *
VLADIMIR A. KOZLOV ET AL.: "Effective Modular Assembling of Novel Ligands Starting from (Thio)Phosphorylated Anilines" *

Similar Documents

Publication Publication Date Title
WO2021139499A1 (en) Preparation method for and application of chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand and iridium catalyst thereof
CN108863969B (en) Synthesis method of 4-allyl-3, 5-disubstituted isoxazole
CN111620793B (en) Preparation method of chiral nitrile compound
CN110437129B (en) Simple method for synthesizing 3-ether-based isoindolinone compound
CN113912577B (en) Rockwell intermediate, rockwell and its derivative, and preparation and application
CN111925356B (en) Synthesis method and application of chiral quinoline-imidazoline ligand
CN113683559A (en) Method for preparing heterocyclic o-iodosulfide
CN112430249A (en) Metal complex and preparation method thereof
CN113024611B (en) N-heterocyclic carbene cyclic palladium compound and preparation method and application thereof
CN112574041B (en) Synthesis method of chiral beta hydroxyl 1,3-dicarbonyl compound
Seidel et al. C 2-Symmetric (SO) N (SO) Sulfoxide Pincer Complexes of Mg and Pd: Helicity Switch by Ambidentate S/O-Coordination and Isolation of a Chiral Pd-Sulfenate
CN103748065B (en) The manufacture method of 2-alkenyl amine compound
CN112010910B (en) Chiral ferrocene homoallylamine derivative and synthesis method and application thereof
CN112409408A (en) Chiral phosphorus sulfur compound and Michael addition method thereof
CN117050050A (en) Alkynyl-sulfur ylide compound and preparation method thereof
CN112979513A (en) Chiral sulfoxide containing styrene monomer and preparation method thereof
CN111499542A (en) Preparation method of cycloenone compound containing α -cyano substituted quaternary carbon center
CN113387837B (en) Photo-oxidation-reduction catalysis method
CN109134338A (en) Pyrrolidines tertiary amine is the alpha-aminonitriles compounds process for production thereof of substrate
CN112479948A (en) Beta-sulfuryl chiral amino compound and preparation method thereof
CN113429323B (en) Preparation method of sulfonyl substituted styrene type axial chiral compound
CN113024604B (en) Preparation method of C3-alkenylated 2-pyridone derivative
CN111362832A (en) Cyclopropane compound and preparation method and application thereof
CN113861237B (en) Organophosphorus ligand, preparation method and application thereof
CN109942612B (en) Diyne enamine compound and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination